Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines - PubMed (original) (raw)
. 1995 Jan 15;55(2):408-13.
Affiliations
- PMID: 7812973
Sigma-1 and sigma-2 receptors are expressed in a wide variety of human and rodent tumor cell lines
B J Vilner et al. Cancer Res. 1995.
Abstract
Thirteen tumor-derived cell lines of human and nonhuman origin and from various tissues were examined for the presence and density of sigma-1 and sigma-2 receptors. Sigma-1 receptors of a crude membrane fraction were labeled using [3H](+)-pentazocine, and sigma-2 receptors were labeled with [3H]1,3-di-o-tolylguanidine ([3H]DTG); in the presence or absence of dextrallorphan. [3H](+)-Pentazocine-binding sites were heterogeneous. In rodent cell lines (e.g., C6 glioma, N1E-115 neuroblastoma, and NG108-15 neuroblastoma x glioma hybrid), human T47D breast ductal carcinoma, human NCI-H727 lung carcinoid, and human A375 melanoma, [3H](+)-pentazocine bound to high- and low-affinity sites with Kd1 = 0.67-7.0 nM, Bmax1 = 25.5-108 fmol/mg protein, Kd2 = 127-600 nM, and Bmax2 = 942-5431 fmol/mg protein. However, [3H](+)-pentazocine bound to a single site in other cell lines. In human U-138MG glioblastoma, SK-N-SH neuroblastoma, and LNCaP.FGC prostate, Kd = 28-61 nM and Bmax = 975-1196 fmol/mg protein, whereas in ThP-1 leukemia Kd = 146 nM and Bmax = 1411 fmol/mg protein. The sigma-1-like nature of [3H](+)-pentazocine-binding sites was confirmed by competition studies which revealed high affinity for haloperidol and enantioselectivity for (+)-pentazocine over (-)-pentazocine. Interestingly, human MCF-7 breast adenocarcinoma showed little or no specific binding of [3H](+)-pentazocine, suggesting the absence of sigma-1 receptors in this cell line. All cell lines examined expressed a high density of sigma-2 receptors with Kd values for [3H]DTG ranging from 20 to 101 nM and Bmax values of 491 to 7324 fmol/mg protein. Competition studies indicated possible heterogeneity of sigma-2 receptors. While sites labeled by [3H]DTG in all cell lines tested exhibited affinity for haloperidol and preference for (-)-pentazocine over the (+)-enantiomer, human cell lines generally showed 4- to 7-fold lower affinity for haloperidol and approximately 10-fold lower affinity for (-)-pentazocine compared with the rodent cell lines. The high density of sigma-1 and sigma 2-binding sites in these cell lines suggests important cellular functions in cancer, as well as potential diagnostic utility for tumor-imaging agents which target sigma sites. These cell lines may be useful as model systems in which to study the functions of sigma sites in normal tissues, as well as their possible role in tumor biology.
Similar articles
- Rat liver and kidney contain high densities of sigma 1 and sigma 2 receptors: characterization by ligand binding and photoaffinity labeling.
Hellewell SB, Bruce A, Feinstein G, Orringer J, Williams W, Bowen WD. Hellewell SB, et al. Eur J Pharmacol. 1994 Jun 15;268(1):9-18. doi: 10.1016/0922-4106(94)90115-5. Eur J Pharmacol. 1994. PMID: 7925616 - Targeting sigma receptor-binding benzamides as in vivo diagnostic and therapeutic agents for human prostate tumors.
John CS, Vilner BJ, Geyer BC, Moody T, Bowen WD. John CS, et al. Cancer Res. 1999 Sep 15;59(18):4578-83. Cancer Res. 1999. PMID: 10493511 - Early development of sigma-receptor ligands.
Narayanan S, Bhat R, Mesangeau C, Poupaert JH, McCurdy CR. Narayanan S, et al. Future Med Chem. 2011 Jan;3(1):79-94. doi: 10.4155/fmc.10.279. Future Med Chem. 2011. PMID: 21428827 Review. - [5-hydroxytryptamine and neoplasm growth].
Rudzit EA, Mal'tseva LF. Rudzit EA, et al. Patol Fiziol Eksp Ter. 1970 Jul-Aug;14(4):84-93. Patol Fiziol Eksp Ter. 1970. PMID: 4927762 Review. Russian. No abstract available.
Cited by
- Development of tumor-targeting aza-vesamicol derivatives with high affinity for sigma receptors for cancer theranostics.
Mishiro K, Wang M, Hirata S, Fuchigami T, Shiba K, Kinuya S, Ogawa K. Mishiro K, et al. RSC Med Chem. 2022 Jun 30;13(8):986-997. doi: 10.1039/d2md00099g. eCollection 2022 Aug 17. RSC Med Chem. 2022. PMID: 36092143 Free PMC article. - The sigma-1 receptor: a regulator of cancer cell electrical plasticity?
Crottès D, Guizouarn H, Martin P, Borgese F, Soriani O. Crottès D, et al. Front Physiol. 2013 Jul 16;4:175. doi: 10.3389/fphys.2013.00175. eCollection 2013. Front Physiol. 2013. PMID: 23882221 Free PMC article. - Coercing bisphosphonates to kill cancer cells with nanoscale coordination polymers.
Liu D, Kramer SA, Huxford-Phillips RC, Wang S, Della Rocca J, Lin W. Liu D, et al. Chem Commun (Camb). 2012 Mar 11;48(21):2668-70. doi: 10.1039/c2cc17635a. Chem Commun (Camb). 2012. PMID: 22428170 Free PMC article. - Evaluation of the Enantiomer Specific Biokinetics and Radiation Doses of [(18)F]Fluspidine-A New Tracer in Clinical Translation for Imaging of σ₁ Receptors.
Kranz M, Sattler B, Wüst N, Deuther-Conrad W, Patt M, Meyer PM, Fischer S, Donat CK, Wünsch B, Hesse S, Steinbach J, Brust P, Sabri O. Kranz M, et al. Molecules. 2016 Sep 1;21(9):1164. doi: 10.3390/molecules21091164. Molecules. 2016. PMID: 27598110 Free PMC article. - Overexpression of sigma-1 receptor in MCF-7 cells enhances proliferation via the classic protein kinase C subtype signaling pathway.
Wu Y, Bai X, Li X, Zhu C, Wu ZP. Wu Y, et al. Oncol Lett. 2018 Nov;16(5):6763-6769. doi: 10.3892/ol.2018.9448. Epub 2018 Sep 18. Oncol Lett. 2018. PMID: 30405820 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources